Asset 2 Conferences
Verhage, Matthijs - VIB Conferences

Matthijs Verhage

Vrije Universiteit & Amsterdam University Medical Center, NL
Biography

Matthijs Verhage is a professor head of the Functional Genomics Department at the Center for Neurogenomics and Cognitive Research (CNCR), Vrije Universiteit & Amsterdam University Medical Center, Amsterdam, The Netherlands. He is also affiliated with Karolinska Institute, Stockholm, Sweden (SUN project) and the Broad Institute, MIT Cambridge MA, USA (SYNGO project).

He obtained his PhD at the University of Amsterdam in 1990 (cum laude) and received post-doctoral training at the labs of prof. David G. Nicholls (Dundee, UK) and the Nobel laureate prof. Thomas C. Südhof (Howard Hughes Medical Institute, Dallas, USA). In 2003 he was appointed as the first chairman of the CNCR. He was co-founder and vice chair of the Dutch NeuroBsik Mouse Phenomics consortium.

Matthijs Verhage was partner of the FP6 consortium EU-Synapse, FP7 consortia EuroSpin and SynSys, co-founder and vice chair of H2020 consortium COSYN, and founder/chair of the BRAINMODEL consortium awarded by ZonMW in 2021.

In 2013 he received the ERC Advanced Grant of the European Research Council.

Matthijs Verhage is chair/member of scientific advisory/review boards of the IPNP (Descartes), Paris, France; the STXBP1 foundation (patient organization, NC, USA); the graduate school Neurosciences in Göttingen, Germany; the European Neuroscience Institute in Göttingen, Germany; the IBS Center for Synaptic Brain Dysfunctions, Daejeon, Korea and the the CIBB, Coimbra, Portugal.

Matthijs Verhage is inventor on patent applications related to gene therapy and he is founder/director of Alea Biotech, Sylics, Cytospector and Neurospector and consultant/scientific advisor for Life Science companies in The Netherlands, Germany, Spain and Japan.

Speaker at